cabergoline has been researched along with lhrh, ala(6)-gly(10)-ethylamide- in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dastranj-Tabrizi, A; Farzadi, L; Gatrehsamani, F; Kazemi-Shishvan, M; Morteza, G; Ouladesahebmadarek, E; Sayyah-Melli, M; Tehrani-Gadim, S | 1 |
1 trial(s) available for cabergoline and lhrh, ala(6)-gly(10)-ethylamide-
Article | Year |
---|---|
Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes.
Topics: Adult; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Middle Aged; Treatment Outcome; Ultrasonography; Uterine Neoplasms | 2009 |